Hall-1
MULTIPLE MYELOMA
*Scientific Chair :
Fahir Özkalemkaş
,
Mutlu Arat
FREE LIGHT CHAIN ESCAPE IN MULTIPLE MYELOMA: IS IT AN EARLY CLUE OF AGGRESSIVE PROGRESSION? Boran Yavuz (22:00 - 23:00)
COMPARISON OF CANCER AND AGING RESEARCH GROUP SCORE (CARG) AND COMORBIDITY INDEX SCORES IN MULTIPLE MYELOMA PATIENTS Mehmet Baysal (22:00 - 23:00)
POSTINDUCTION FDG-PET IMAGING IMPROVES THE IMPACT OF BIOCHEMICAL RESPONSE ASSESSMENT ON TRANSPLANT OUTCOME Güldane Cengiz Seval (22:00 - 23:00)
PATIENT RELATED FACTORS OVERRIDE LENALIDOMIDE MAINTENANCE AS A FACTOR OF SEVERITY FOR COVID-19 INFECTION Ekin Kırcalı (22:00 - 23:00)
PACE-LIKE REGIMENS IN THE TREATMENT OF RELAPSED/ REFRACTORY MULTIPLE MYELOMA Aylin Fatma Karataş (22:00 - 23:00)
THE IMPACT OF PRETRANSPLANT IMMUNOMODULATORY DRUGS ON CMV REACTIVATION Atilla Uslu (22:00 - 23:00)
Hall-2
PRECLINIC/GENETIC
*Scientific Chair :
Muhlis Cem Ar
,
Alphan Küpesiz
MYD88 EXPRESSION IN PRIMARY AND SECONDARY CNS LYMPHOMAS Berrin Balık Aydın (22:00 - 23:00)
PHENOTYPES OF BONE MARROW MONOCYTES IN STEM CELL TRANSPLANTATION FOR ACUTE LEUKEMIA: A DESCRIPTIVE PILOT STUDY Ekin Kırcalı (22:00 - 23:00)
THE IGLV3-21 LIGHT CHAIN ANALYSIS IN IR-RELATED CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS Nadiia Bilous (22:00 - 23:00)
KILLER IMMUNOGLOBULIN LIKE HAPLOTYPE BB IS OBSERVED MORE FREQUENTLY AMONG MYELOMA CASES COMPARED TO HEALTHY CONTROLS Yalım Akın (22:00 - 23:00)
MUTATION PROFILE OF THE PATIENTS TESTED WITH NEXT GENERATION SEQUENCING AND CLINICAL IMPLICATIONS Yaşa Gül Mutlu (22:00 - 23:00)
Hall-3
INFECTION/QUALITY OF LIFE
*Scientific Chair :
Adalet Meral Güneş
,
Mustafa Nuri Yenerel (Turkey)
DETERMINATION OF INFECTION FREQUENCY IN PATIENTS USING RUXOLITINIB DUE TO GRAFT VERSUS HOST DISEASE Hülya Yılmaz (22:00 - 23:00)
EFFICACY OF ANTI-IL-6 ANTIBODY IN THREE PATIENTS WITH COVID-19 INFECTION AND MULTIPLE MYELOMA Anıca Dıvac (22:00 - 23:00)
ASSESSMENT OF POSSIBLE RISK FACTORS FOR THE DEVELOPMENT OF CORONAVIRUS INFECTION IN PATIENTS WITH HEMATOLOGICAL CANCERS Inna Kamaeva (22:00 - 23:00)
OUR CENTER EXPERIENCE OF MULTIPLE MYELOMA PATIENTS WITH COVID-19 Mehmet Sezgin Pepeler (22:00 - 23:00)
EVALUATION OF POSSIBLE EFFECTS OF THE COVID-19 PANDEMIC ON FEBRILE NEUTROPENIA EPISODES IN CHILDREN WITH ACUTE LEUKEMIA Şebnem Yılmaz (22:00 - 23:00)
QUALITY OF LIFE MEASURES OF THE PATIENTS WHO ARE DIAGNOSED WITH HEMATOLOGICAL MALIGNANCIES AND TIME EFFECT ON PARAMETERS Berrin Balık Aydın (22:00 - 23:00)
Hall-4
LEUKEMIA/LYMPHOMA
*Scientific Chair :
Düzgün Özatlı
,
Şebnem Yılmaz
EVALUATION OF CLINICAL AND LABORATORY FINDINGS AT DIAGNOSIS AND RELAPSE IN CHILDREN WITH ACUTE LEUKEMIA Şebnem Yılmaz (22:00 - 23:00)
PERSISTENT POLYCLONAL B-CELL LYMPHOCYTOSIS WITH BINUCLEATED LYMPHOCYTES (PPBL) Berrin Balık Aydın (22:00 - 23:00)
ANALYSIS OF FACTORS PREDICTING EFFICACY OF IMATINIB IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA: A RETROSPECTIVE ANALYSIS Mesut Tığlıoğlu (22:00 - 23:00)
DIAGNOSTIC CHALLENGES AND CONSEQUENT THERAPEUTIC DILEMMAS ENCOUNTERED IN CLASSIFYING ACUTE MYELOID LEUKEMIAS Mürüvvet Seda Aydın (22:00 - 23:00)
CLINICAL OUTCOMES AND TREATMENT PATTERNS OF PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA:MULTICENTER RETROSPECTIVE ANALYSIS Serkan Güven (22:00 - 23:00)
GIANT MASS IN THE EYELID: T CELL LYMPHOMA Ferda Can (22:00 - 23:00)
Hall-5
LYMPHOMA
*Scientific Chair :
Şule Mine Öztürk
,
Ebru Koca
IS SURGICAL EXCISIONAL BIOPSY STILL THE GOLD STANDARD DIAGNOSTIC APPROACH IN LYMPHOMAS? Yaşa Gül Mutlu (22:00 - 23:00)
BRENTUXIMAB VEDOTIN CONSOLIDATION AFTER AUTO-SCT IN HIGH-RISK HODGKIN’S LYMPHOMA: MULTI-CENTER RETROSPECTIVE STUDY Meltem Olga Akay (22:00 - 23:00)
EVALUATION OF PD-1/ PD-L1 EXPRESSION, TUMOR MICROENVIRONMENT AND PROGNOSTIC FACTORS IN DIFFUSE LARGE B CELL LYMPHOMA Guldidar Basmacı (22:00 - 23:00)
BROWN ADIPOSE TISSUE FORMATION DUE TO NIVOLUMAB TREATMENT Elçin Erdoğan Yücel (22:00 - 23:00)
PRIMARY GASTRIC NK/T CELL LYMPHOMA WITH T CELL PHENOTYPE: A RARE EBV RELATED LOCALLY INVOLVED AGRESSIVE LYMPHOMA CASE. Derya Koyun (22:00 - 23:00)
THE EFFECT OF THE CELL OF ORIGIN USING HANS ALGORITHM ON PROGNOSIS IN DIFFUSE LARGE B CELL LYMPHOMAS Taha Kars (22:00 - 23:00)
